Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Neostigmine Methylsulfate Patent Expiration

Neostigmine Methylsulfate was first introduced by Exela Pharma Sciences Llc in its drug Bloxiverz on May 31, 2013. Another drug containing Neostigmine Methylsulfate is Neostigmine Methylsulfate. 18 different companies have introduced drugs containing Neostigmine Methylsulfate.


About Veterinary Neostigmine Methylsulfate

Neostigmine Methylsulfate is used in a drug marketed by 1 company: Intervet Inc.

Other drugs containing Neostigmine Methylsulfate are: Stiglyn 1:500 .

Neostigmine Methylsulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Neostigmine Methylsulfate Generic API Manufacturers

Several generic applications have been filed for Neostigmine Methylsulfate. The first generic version for Neostigmine Methylsulfate was by Hikma Pharmaceuticals Usa Inc and was approved on Dec 28, 2015. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Nov 2, 2023.

Given below is the list of companies who have filed for Neostigmine Methylsulfate generic, along with the locations of their manufacturing plants worldwide.